###begin article-title 0
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fascin-1</italic>
###xml 85 90 <span type="species:ncbi:9606">Human</span>
Fascin-1 Promoter Activity Is Regulated by CREB and the Aryl Hydrocarbon Receptor in Human Carcinoma Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: YH JCA. Performed the experiments: YH DWL. Analyzed the data: YH DWL JCA. Wrote the paper: YH JCA.
###end p 1
###begin p 2
Current address: Shizuoka Cancer Canter, Nagaizumi-cho, Shizuoka, Japan
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 205 213 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
Fascin is an actin-bundling protein that is absent from most normal epithelia yet is upregulated in multiple forms of human carcinoma, where its expression correlates clinically with a poor prognosis. How fascin-1 transcription is activated in carcinoma cells is largely unknown, although the hypothesis of regulation by beta-catenin signaling has received attention. The question is important because of the clinical significance of fascin expression in human carcinomas.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 265 273 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1178 1183 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 259 264 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 1065 1070 <span type="species:ncbi:9606">human</span>
Through comparative genomics we made an unbiased analysis of the DNA sequence of the fascin-1 promoter region from six mammalian species. We identified two regions in which highly conserved motifs are concentrated. Luciferase promoter reporter assays for the human fascin-1 promoter were carried out in fascin-positive and -negative human breast and colon carcinoma cells, and in human dermal fibroblasts that are constitutively fascin-positive. In all fascin-positive cells, the region -219/+114 that contains multiple highly conserved motifs had strong transcriptional activity. The region -2953/-1582 appeared to contain repressor activity. By examining the effects of single or multiple point mutations of conserved motifs within the -219/+114 region on transcriptional reporter activity, we identified for the first time that the conserved CREB and AhR binding motifs are major determinants of transcriptional activity in human colon carcinoma cells. Chromatin immunoprecipitations for CREB, AhR or beta-catenin from extracts from fascin-positive or -negative human colon carcinoma cells identified that CREB and AhR specifically associate with the -219/+114 region of the FSCN1 promoter in fascin-positive colon carcinoma cells. An association of beta-catenin was not specific to fascin-positive cells.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN-1</italic>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
Upregulation of fascin-1 in aggressive human carcinomas appears to have a multi-factorial basis. The data identify novel roles for CREB and AhR as major, specific regulators of FSCN-1 transcription in human carcinoma cells but do not support the hypothesis that beta-catenin signaling has a central role.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Lambrechts1">[1]</xref>
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Bruce1">[2]</xref>
###xml 639 642 639 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fscn1</italic>
###xml 862 865 862 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Adams1">[9]</xref>
###xml 1104 1108 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-IacobuzioDonahue1">[10]</xref>
###xml 1109 1113 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Yoder1">[15]</xref>
###xml 1356 1359 1356 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto1">[5]</xref>
###xml 1361 1365 1361 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Pelosi1">[11]</xref>
###xml 1367 1371 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto3">[12]</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto5">[14]</xref>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Puppa1">[17]</xref>
###xml 1483 1487 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto3">[12]</xref>
###xml 1489 1493 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Zigeuner1">[16]</xref>
###xml 1494 1498 1494 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Minn1">[18]</xref>
###xml 626 631 <span type="species:ncbi:10090">mouse</span>
###xml 699 704 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
###xml 1088 1093 <span type="species:ncbi:9606">human</span>
###xml 1140 1145 <span type="species:ncbi:9606">human</span>
Abnormalities of the actin cytoskeleton make important contributions to the ability of carcinoma cells to invade adjacent tissue and metastasise via the blood or lymphatic systems to remote body sites [1]. Many of the actin-associated proteins that are reported to be upregulated in carcinomas, for example ezrin, are also expressed in the corresponding normal epithelium [2], raising uncertainty over their practicality as possible therapeutic targets. In recent years, the actin-bundling protein fascin has emerged as a functionally relevant mediator of carcinoma cell migration, invasion and metastasis in cell culture and mouse models [3]-[8]. Fascin (also known as fascin-1; gene name FSCN1 in human and Fscn1 in mouse) bundles F-actin into tightly packed parallel arrays that contribute to cell migration by providing rigidity to filopodia and microspikes [9]. Fascin is of considerable interest as a biomarker or potential therapeutic target because it is not expressed by simple epithelia and is low or absent in stratified epithelia, yet is strongly upregulated in most forms of human carcinoma [10]-[15]. Notably, in all forms of human carcinoma examined to date, high tumour expression of fascin protein is of clinical significance and is associated with a poor prognosis in carcinomas of the lung, oesophagus, stomach, colon, breast and kidney [5], [11], [12], [14]-[17]. Fascin expression has also been correlated with local lymph node metastasis and distant metastasis [12], [16]-[18].
###end p 10
###begin p 11
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-IacobuzioDonahue1">[10]</xref>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto4">[13]</xref>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 244 252 244 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Edwards1">[19]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-DeArcangelis1">[21]</xref>
###xml 610 618 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ross1">[22]</xref>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-AlAlwan1">[23]</xref>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ross1">[22]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ross2">[24]</xref>
###xml 811 819 811 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 977 985 977 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1209 1213 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ross3">[25]</xref>
###xml 1215 1219 1215 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Bros1">[26]</xref>
###xml 1274 1279 1274 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1555 1560 1555 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1611 1615 1611 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Megiorni1">[27]</xref>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
###xml 805 810 <span type="species:ncbi:10090">mouse</span>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
###xml 971 976 <span type="species:ncbi:9606">human</span>
###xml 1040 1045 <span type="species:ncbi:9606">human</span>
###xml 1228 1233 <span type="species:ncbi:9606">human</span>
Increased levels of fascin-1 transcript have been reported in multiple human carcinomas (e.g. [10], [13]). The mechanism by which fascin-1 transcription is upregulated in carcinomas is not understood. Normal mammalian cells with high levels of fascin-1 transcripts include dendritic cells and neuronal cells [19]-[21] and initial analyses of mechanisms for transcriptional regulation have been made in these cells. In human or mouse Langerhans and dendritic cells, fascin is absent from immature cells and becomes highly expressed during terminal differentiation; this process involves increased levels of the fascin-1 transcript [22], [23]. As a structural component of dendrites, fascin contributes to the antigen-presenting activity of mature dendritic cells [22], [24]. A 2.6 kb 5' flanking region of mouse fascin-1 is sufficient to drive promoter reporter activity in mature mouse dendritic cells but not in immature cells; similarly, a 3.1 kb 5' flanking region of human fascin-1 specifically confers induction of reporters in mature human dendritic cells and other non-transformed fascin-positive cells. No transcriptional regulation activity was detected in the first intron or 3' untranslated region [25], [26]. In NT2 human neuronal precursor cells, the levels of FSCN1 transcript and protein increased during retinoic acid-induced terminal differentiation. This effect depended on the transcriptional coactivator and histone acetyltransferase CBP (cAMP response element binding protein (CREB)-binding protein). However, the relevance of CBP to FSCN1 promoter activity was not addressed in this study [27].
###end p 11
###begin p 12
###xml 332 336 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Polakis1">[28]</xref>
###xml 411 419 405 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 460 463 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 465 468 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 485 488 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 568 573 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fscn1</italic>
###xml 653 658 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fscn1</italic>
###xml 770 775 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fscn1</italic>
###xml 905 908 890 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 973 981 958 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1019 1024 1004 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1150 1155 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1562 1570 1544 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1676 1679 1658 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1701 1706 1683 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1947 1955 1929 1937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 561 566 <span type="species:ncbi:10090">mouse</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1186 1191 <span type="species:ncbi:9606">human</span>
###xml 1737 1742 <span type="species:ncbi:9606">human</span>
###xml 1973 1978 <span type="species:ncbi:9606">human</span>
Dysregulation of the Wnt/beta-catenin signalling pathway is a frequent cause of tumour progression in colorectal carcinomas. The transcriptional activity of beta-catenin is mediated through its interaction with members of the TCF/LEF (T cell factor/ lymphocyte enhancer-binding factor 1) family of DNA-binding transcription factors [28]. There are conflicting reports on whether the transcriptional activity of fascin-1 is regulated by beta-catenin signalling [3], [8]. Grothey et al. [3] identified multiple candidate T cell factor (TCF) binding sites in the (mouse) Fscn1 promoter, but found no effect of either TCF or beta-catenin over-expression on Fscn1 promoter activity when tested in human MDA-MB-435 cells. In contrast, a later study demonstrated regulation of Fscn1 promoter reporter activity upon expression of either a stabilised beta-catenin or dominant-negative TCF4 in two human cell lines [8]. Because both of these studies focused on analysis of the mouse fascin-1 promoter, it remains unclear whether FSCN1 could be a direct target of beta-catenin/TCF transcriptional regulation in human carcinomas. Understanding the mechanisms of FSCN1 transcriptional regulation in human carcinoma cells is an important question because it may lead to novel prognostic tools for early identification of the most biologically aggressive carcinomas, and/or potential novel therapeutic strategies to reduce tumour metastasis through inhibition of fascin expression. Here, we first took the unbiased approach of identifying evolutionary conserved regions of the fascin-1 promoter region in mammals by comparative genomics. We built on these data to analyse experimentally the cis-acting mechanisms of FSCN1 transcriptional regulation in human colon and breast carcinoma cells. Our novel findings demonstrate previously unidentified roles of cAMP response element-binding protein (CREB) and the aryl hydrocarbon receptor (AhR) in the regulation of fascin-1 transcription in human carcinoma cells.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
Phylogenetic analysis of conserved motifs in the 5' flanking region of mammalian fascin-1 genes
###end title 14
###begin p 15
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 229 244 229 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglidytes</italic>
###xml 246 260 246 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 262 284 262 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis lupus familiaris</italic>
###xml 286 298 286 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 303 320 303 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 246 260 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 262 284 <span type="species:ncbi:9615">Canis lupus familiaris</span>
###xml 286 298 <span type="species:ncbi:10090">Mus musculus</span>
###xml 303 320 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 330 333 <span type="species:ncbi:10116">rat</span>
###xml 338 348 <span type="species:ncbi:9598">chimpanzee</span>
###xml 535 542 <span type="species:ncbi:9031">chicken</span>
To identify evolutionarily conserved sequences in the 5' flanking region of mammalian fascin-1 genes, we extracted 5.5 kb of DNA sequence 5' to the ATG codon of the fascin-1 gene from the genomes of human and five other mammals: Pan troglidytes, Macaca mulatta, Canis lupus familiaris, Mus musculus and Rattus norvegicus. For the rat and chimpanzee, a full sequence for the entire 5.5 kb region is not yet available, thus our detailed analysis focused on a 2 kb 5' flanking region for which all six species could be fully aligned. The chicken (as an example of an avian) could not be included because this region of its genome is not yet sequenced completely.
###end p 15
###begin p 16
###xml 122 131 122 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s001">Figure S1</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s001">Figure S1</xref>
###xml 621 629 621 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 950 959 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s001">Figure S1</xref>
###xml 374 377 <span type="species:ncbi:9615">dog</span>
###xml 604 609 <span type="species:ncbi:9606">human</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
###xml 765 770 <span type="species:ncbi:9606">human</span>
To examine sequence conservation across the 2 kb 5' flanking regions, a TCOFFEE multiple sequence alignment was prepared (Figure S1). The alignment demonstrated that the three primate genome sequences are near identical throughout this region apart from scattered individual single nucleotide differences and some short additional sequences in the macaque. In contrast, the dog and rodent sequences contained multiple nucleotide insertions and /or deletions, resulting in multiple gap insertions throughout the alignment (Figure S1). Overall, the sequence conservation between the 5' flanking regions of human and rodent fascin-1 was much lower than between the primates (for example, the human and mouse sequences have 54.6% identity over the 2 kb region, whereas human and macaque are 90.5% identical). The most significant region of conservation across all six species was within a 200 bp region, 5' to and including the translational start site (Figure S1).
###end p 16
###begin p 17
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Blanchette1">[29]</xref>
###xml 530 536 530 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 698 704 698 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 1189 1196 1189 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1A</xref>
###xml 1366 1373 1366 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1A</xref>
###xml 958 961 <span type="species:ncbi:9615">dog</span>
###xml 1214 1217 <span type="species:ncbi:9615">dog</span>
For an independent second methodology, the six sequences were analysed by phylogenetic footprinting with the algorithm FootPrinter. This algorithm identifies the most conserved nucleotide motifs within a set of homologous DNA sequences, under the premise that functional regulatory elements are more highly conserved under natural selection than non-functional DNA sequences [29]. The "footprints" obtained demonstrated complete conservation of multiple motifs within the 200 nucleotide region 5' to the translational start site (Fig. 1, designated region A). A second region that included a high density of well-conserved motifs was located between -1200 and -1000 in the three primate sequences (Fig. 1, designated region B). Within region B, the same motifs were conserved in all six species, but, in agreement with the gapping noted in the TCOFFEE alignment, the exact positioning of the motifs relative to the start site was different in the rodent and dog sequences compared to the primates. Further 5' to region B (i.e., between -1876 to -1176), the three primate sequences contained additional conserved motifs in near-identical locations relative to the translational start site (Fig. 1A). The rodent and dog sequences had different numbers and locations of conserved motifs within this region (e.g., the absence of blue-coded motifs in region -1676/-1576, Fig. 1A).
###end p 17
###begin title 18
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
Identification of evolutionarily conserved motifs in the fascin-1 promoter region by phylogenetic footprinting analysis.
###end title 18
###begin p 19
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 591 596 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
###xml 725 735 <span type="species:ncbi:9598">chimpanzee</span>
###xml 740 743 <span type="species:ncbi:9615">dog</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 899 904 <span type="species:ncbi:9606">human</span>
A, 2 kb of genomic DNA sequence 5' to the translational start codon of fascin-1 was extracted from the indicated mammalian genomes and analysed for conserved motifs by the FootPrinter algorithm. On each line, alignment blocks are indicated by thin coloured lines. The vertical bars indicate the positions of motifs that are conserved across the genomes, with each category of motif identified in a different colour. Corresponding motifs in different sequences are in the same colour. The numbering scheme is the same as that used in other figures, with the transcriptional start site in the human genome as +1. Asterisk indicates the position of a TCF motif identified by the rVista algorithm that is conserved in the human, chimpanzee and dog genomes. B, the DNA sequence and conserved motifs within Region A from the human genome. C, the DNA sequence and conserved motifs within Region B from the human genome. In B and C, motifs are in the same colour code as in A. The larger the font the stronger the conservation of the motif: the largest font indicates complete conservation in all six species.
###end p 19
###begin title 20
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 78 83 <span type="species:ncbi:9606">human</span>
Mapping FSCN1 transcriptional activity in fascin-positive and fascin-negative human carcinoma cells
###end title 20
###begin p 21
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 653 659 653 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g002">Fig. 2</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 524 527 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
On the basis of the comparative genomic analysis, we hypothesised that either or both of regions A and B might have significant regulatory roles in controlling FSCN1 transcription in human carcinoma cells. To test this idea, we generated a set of luciferase reporter constructs to compare the activity of a 3.1 kb 5' flanking region of FSCN1 (comprising the region -2956/+114) with truncation mutants that included or deleted either or both of regions A and B, or separated these regions from the distal conserved motifs. A CMV promoter-driven luciferase reporter was included as a positive control and a promoter-less luciferase as a negative control (Fig. 2).
###end p 21
###begin title 22
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
Schematic diagram of FSCN1 promoter-luciferase reporter constructs.
###end title 22
###begin p 23
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 239 245 239 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
The scale bar indicates the FSCN1 5' flanking region. The name of each construct corresponds to the 5' and 3' junctions within the FSCN1 promoter, relative to the proposed transcriptional start site. The numbering scheme is the same as in Fig. 1. Broad black lines indicate FSCN1 5' flanking regions; dashed line represents an internal deletion. Thin black lines represent sequence from pcDNA3.1, 5' to the firefly luciferase cDNA.
###end p 23
###begin p 24
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto5">[14]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Yoder1">[15]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Puppa1">[17]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Jawhari1">[4]</xref>
###xml 356 359 356 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto2">[7]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Horwitz1">[30]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Lacroix1">[31]</xref>
###xml 565 572 565 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3A</xref>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Adams2">[32]</xref>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
###xml 726 738 <span type="species:ncbi:60711|species:ncbi:9534">green monkey</span>
The luciferase reporter activity of these constructs was tested in cells derived from human colon and breast adenocarcinomas, because fascin expression is strongly associated with a poor prognosis in these carcinomas [14], [15], [17]. The human colon adenocarcinoma cell line SW480 has high fascin expression, whereas SW1222 has negligible expression [4], [7]. T47D is a well-differentiated, fascin-negative carcinoma cell line derived from an invasive ductal carcinoma [30] and MDA-MB-231 is an invasive breast carcinoma line [31] with moderate fascin expression (Fig. 3A). For comparison with promoter activity in a normal cell type, we examined human dermal fibroblasts (HDF) that are constitutively fascin-positive. COS-7 green monkey kidney cells were included for comparison as fascin-positive, [32], transformed primate cell line of epithelial origin.
###end p 24
###begin title 25
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
FSCN1 promoter reporter activity in fascin-positive and -negative cells.
###end title 25
###begin p 26
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 335 340 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 345 348 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 584 587 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 702 705 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
A, comparison of fascin protein levels in MDA-MB-231 and T47D breast carcinoma cells. Whole cell extracts from the equivalent of 4.5x104 cells/lane were resolved on 10% SDS-PAGE gels under reducing conditions, transferred to PVDF membrane and immunoblotted with the indicated antibodies. beta-actin was used as a loading control. B-G, FSCN1 and CMV promoter activities were analysed by dual luciferase reporter assays in the six indicated cells. In each experiment, firefly luciferase activities were normalized against Renilla luciferase activity. In each graph, the mean normalized CMV promoter activity for that cell type is set as 1 and FSCN1 reporter activities are expressed as a fraction of the CMV reporter activity. Each column represents the mean from 3 independent experiments, bars indicate s.e.m.
###end p 26
###begin p 27
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 259 270 259 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3B, 3G</xref>
###xml 424 435 424 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3C, 3D</xref>
###xml 572 582 572 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3E&#8211;3G</xref>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 787 794 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3G</xref>
###xml 18 21 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 107 110 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 676 679 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 732 735 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 763 767 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
In all cells, the CMV promoter was more active that the 3.1 kb FSCN1 promoter. When normalized relative to CMV promoter activity, the highest reporter activity of the 3.1 kb FSCN1 promoter was detected in SW480, that have the highest level of fascin protein (Fig. 3B, 3G). SW1222 cells or T47D do not express fascin protein, yet a low level of 3.1 kb FSCN1 promoter-luciferase reporter activity was detected in these cells (Fig. 3C, 3D). MDA-MB-231, COS-7 and HDF cells, with moderate expression of fascin, had similar intermediate levels of luciferase reporter activity (Fig. 3E-3G). The level of 3.1 kb FSCN1 reporter activity in COS-7 cells appeared low as a ratio against CMV promoter activity because of the very high level of CMV promoter activity in these SV40-transformed cells (Fig. 3G).
###end p 27
###begin p 28
###xml 173 178 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 189 196 185 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3B</xref>
###xml 281 291 277 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3B&#8211;3F</xref>
###xml 391 396 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 424 430 420 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3</xref>
###xml 599 604 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 640 646 636 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3</xref>
###xml 648 649 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 817 823 813 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3</xref>
###xml 1055 1061 1051 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g003">Fig. 3</xref>
###xml 1231 1236 1227 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1144 1149 <span type="species:ncbi:9606">human</span>
With regard to the deletion mutants, in SW480 cells, the distal 5' flanking region -2952(Delta)/+114 activated less than half the luciferase reporter activity of the 3.1 kb FSCN1 promoter (Fig. 3B). A similar fold reduction in activity was observed in all other cell lines tested (Fig. 3B-3F). In contrast, the reporter activity of the -1582/+114 region was equivalent to that of the 3.1 kb FSCN1 promoter in all the cells (Fig. 3). In all cells except T47D the -219/+114 promoter fragment, that includes only conserved region A, had significantly increased reporter activity compared to the 3.1 kb FSCN1 promoter or the -1582/+114 region (Fig. 3; p = 0.0002 for SW480 cells). Further truncation to -50/+114, thus deleting region A, dramatically reduced luciferase reporter activity in SW480 and all the other cells (Fig. 3). Residual luciferase reporter activity in the carcinoma cells was completely abolished by deletion of an additional seven nucleotides: the construct -43/+114 had the same negligible activity as a promoterless luciferase reporter (Fig. 3). These results demonstrated that positive regulatory sequence elements active in human carcinoma and fibroblast cells are concentrated within the region -219 to -43 of FSCN1.
###end p 28
###begin title 29
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
Transcriptional activation by the -219/+114 region of FSCN1 depends on multiple DNA sequence elements
###end title 29
###begin p 30
###xml 100 109 100 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s001">Figure S1</xref>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1B</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 421 428 421 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 684 691 684 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 822 829 822 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4B</xref>
###xml 910 916 910 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 1111 1118 1111 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 1246 1253 1246 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 496 501 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1403 1408 <span type="species:ncbi:9606">human</span>
###xml 1413 1423 <span type="species:ncbi:9598">chimpanzee</span>
As demonstrated by the bioinformatics analyses, the region -219/+114 is well- conserved in mammals (Figure S1), and contains multiple conserved motifs (Fig. 1B, conserved region A). To identify candidate transcription factor binding motifs within this region of FSCN1, DNA sequences from the six mammals corresponding to -219/+114 of human FSCN1 were analysed individually by Match 1.0 Public and pairwise by rVista (see Methods). Core candidate motifs identified with probability scores >0.8 in human and at least one other species were chosen for further experimental analysis. Overall, multiple candidate transcription factor binding sites were identified that met these criteria (Fig. 4A). Of these, only the CREB and TCF motifs were completely conserved across all six species and the AhR motif was highly conserved (Fig. 4B). These motifs also corresponded to conserved motifs identified by FootPrinter (Fig. 1). Additional candidate motifs identified in the human sequence included multiple USF or Pax-4 (paired box 4) sites, a SREBP-1 (sterol regulatory element-binding protein1) site and an AP-4 site (Fig. 4A). For clarity, we will refer to the motifs as motifs 1 to 9, with motif 1 being the most 5' to the transcriptional start site (Fig. 4A). With the exception of the Pax-4 motif (motif 3), the additional motifs were conserved only in primates, or, in the case of motifs 1 and 5, between human and chimpanzee only.
###end p 30
###begin title 31
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
Identification of candidate transcription factor binding sites in the -219/+114 5' flanking region of FSCN1.
###end title 31
###begin p 32
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s001">Figure S1</xref>
###xml 361 367 361 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
A, The DNA sequence of the -219/+114 region of FSCN1 (from GenBank NC_000007.12). Candidate core motif binding sites for the indicated transcription factors were identified with the Match 1.0 Public, rVISTA or Target explorer algorithms, in combination with evaluation of the evolutionary conservation of the identified motifs in six mammals (see Figure S1 and Fig. 1). Motifs selected for mutagenesis are numbered 1-9 and are shown boxed. Nucleotide substitutions introduced in the point mutants are shown below the sequence. Nucleotides corresponding to the TATA box and predicted transcriptional start site are in bold. Restriction enzyme sites added for subcloning of the parent wildtype DNA are in bold and underlined. B, multiple sequence alignment demonstrating the conservation of the AhR, CREB and TCF motifs (motifs 6, 8 and 9) in mammals.
###end p 32
###begin p 33
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 246 253 246 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5A</xref>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 434 441 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 443 450 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5A</xref>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 642 643 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 680 681 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 787 794 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 917 924 917 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
To test the functional relevance of the candidate transcription factor binding sites, point mutations were prepared to inactivate each of the identified conserved motifs in the context of the -219/+114 FSCN1 luciferase reporter plasmid (Fig. 4A, Fig. 5A). The luciferase reporter activity of the mutants was compared to that of wild-type FSCN1 -219/+114 in SW480 cells (Fig. 5B). Mutation of the candidate AhR binding motif (motif 6, Fig. 4A, Fig. 5A), resulted in a significant (p = 0.0305) reduction in transcriptional reporter activity. Similarly, mutations of the candidate USF motif (motif 7, p = 0.03), the CREB binding motif (motif 8, p<0.0001), or the TCF motif (motif 9, p = 0.004) each resulted in significantly reduced transcriptional reporter activity compared to wild-type (Fig. 5B). In contrast, mutation of sites 1, 2, 3, 4 or 5 had no statistically significant effect on luciferase reporter activity (Fig. 5B). The general significance of these results was assessed by repeating the analysis in COS-7 and MDA-MB-231 cells. Identical results were obtained, with the exception of the TCF motif (motif 9), for which the mutation did not reduce transcriptional reporter activity in COS-7 cells (data not shown).
###end p 33
###begin title 34
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
The transcriptional activity of FSCN1 -219/+114 promoter region is due to multiple sequence motifs.
###end title 34
###begin p 35
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 218 224 218 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4</xref>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 730 735 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 947 948 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
A, Schematic view of the single and combined point mutations prepared in the FSCN1 -219/+114 luciferase reporter construct. In the top line, each numbered box represents the correspondingly numbered motif, as shown in Fig. 4. The candidate transcription factor binding sites disrupted by each point mutation are listed above each box. Each lower line represents a different construct; black boxes represent the mutated motifs. Not to scale. B, Comparative analysis of the transcriptional activity of the point mutant FSCN1 -219/+114 promoter reporter constructs. All constructs were analysed by luciferase reporter assay in SW480 cells, with normalization to Renilla luciferase activity. The mean normalized activity of wild-type FSCN1 -219/+114 is set as 1 and the activities of the mutant constructs are expressed as a fraction of the wildtype. Each column represents the mean of 3 to 4 independent experiments, bars indicate s.e.m. Significant p values are stated in the text.
###end p 35
###begin p 36
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 584 585 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 623 630 623 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 777 784 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
Because several of the point mutants decreased but did not abolish transcriptional reporter activity in multiple cells, selected combinatorial point mutants were generated and tested in SW480 cells. Double mutations of the BSAP and CREB motifs; USF and CREB motifs, or the AP-1 and CREB motifs, did not further decrease reporter activity compared to the CREB motif mutant alone (Fig. 5B). In contrast, the combined mutation of the AhR and CREB motifs inhibited transcriptional activity very strongly in comparison to the individual mutations (p = <0.0001 vs the single AhR mutant and p = 0.0002 vs the single CREB mutant) (Fig. 5B). It was not possible to combine the designed AhR and USF motif mutations because the core motifs overlap extensively in the nucleotide sequence (Fig. 4A).
###end p 36
###begin p 37
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 539 546 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 548 549 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 701 708 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g005">Fig. 5B</xref>
###xml 914 919 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
In view that the double mutant of the AhR and CREB motifs retained a low level of reporter activity, a number of triple point mutants were tested. Combining the motif 1 mutant had only a minor additional effect (Fig. 5B). Inclusion of either the SREB site (motif 3) or AP-1 site (motif 8a) mutant with the AhR and CREB motif mutants did not further decrease reporter activity (Fig. 5B). However, inclusion of the AP-4 site (motif 4) mutant with the AhR and CREB motif mutants resulted in a statistically significant reduction of activity (Fig. 5B, p = 0.02 vs the double AhR and CREB motif mutant). Reporter activity was not further decreased in a quadruple mutant that included the motif 1 mutation (Fig. 5B). These experiments were repeated in COS-7 cells with identical results (data not shown). These data identify the candidate AhR and CREB motifs as major determinants of the transcriptional activity of the FSCN1 -219/-43 region.
###end p 37
###begin title 38
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 119 124 <span type="species:ncbi:9606">human</span>
The transcription factors CREB and AhR are specifically associated with the -219/+7 region of FSCN1 in fascin-positive human carcinoma cells
###end title 38
###begin p 39
###xml 161 168 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4B</xref>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 440 447 440 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6A</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Kimura1">[33]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Soshilov1">[34]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Mayr1">[35]</xref>
###xml 810 817 810 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6A</xref>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Shan1">[36]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Min1">[37]</xref>
###xml 1002 1009 1002 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6B</xref>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 787 792 <span type="species:ncbi:9606">human</span>
On the basis of the above experimental data, and the very strong evolutionary conservation of the candidate CREB and AhR binding motifs between the six mammals (Fig. 4B), we next examined whether CREB and AhR specifically associate with the endogenous FSCN1 promoter in human carcinoma cells. Immunoblot analyses with well-characterised antibodies demonstrated that AhR and CREB were both expressed in all four of the carcinoma cell lines (Fig. 6A). The molecular mass of AhR was consistent with that reported in other studies [33], [34]. Phosphorylation of CREB at residue Ser-133 promotes recruitment of coactivators needed for transcriptional activation [35], and there was no detectable difference in the content of S133-phosphoCREB in the four lines of fascin-positive or -negative human carcinoma cells (Fig. 6A). The antibody used is a sensitive detector of pCREB [36], [37] and indeed differences in pCREB content were apparent when additional cell lines were compared (shown for HT29 cells in Fig. 6B). By immunofluorescence, AhR, CREB and pS133-CREB were located principally in the nuclei of SW1222 and SW480 cells (data not shown).
###end p 39
###begin title 40
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 93 98 <span type="species:ncbi:9606">human</span>
CREB and AhR are specifically associated with the -219/+7 region of FSCN1 in fascin-positive human colon carcinoma cells.
###end title 40
###begin p 41
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 58 63 <span type="species:ncbi:9606">human</span>
A, B, expression of AhR and CREB transcription factors in human carcinoma cells. Whole cell extracts from the equivalent of 4.5x104 cells/lane were resolved on 10% SDS-PAGE gels under reducing conditions, transferred to PVDF membrane and immunoblotted with the indicated antibodies. C, D, detection of CREB and AhR binding to the -219/+7 region of the FSCN1 promoter by chromatin immunoprecipitation from SW480 cells [C] or SW1222 cells [D], as analysed on agarose gels. Sizes of markers are given in nucleotides. E, Bar graph from qRT-PCR analysis showing the relative fold enrichment of the -219/+7 FSCN1 promoter region in test immunoprecipitates relative to the control IgG immunoprecipitate, which is assigned a value of 1. Values are the mean+/-SD from duplicate reactions and 3 separate experiments.
###end p 41
###begin p 42
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 244 251 244 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(GAPDH)</italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 496 503 496 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6C</xref>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 859 866 859 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6D</xref>
###xml 1108 1113 1108 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1126 1133 1126 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 1072 1077 <span type="species:ncbi:9606">human</span>
We used chromatin immunoprecipitation to examine whether AhR and CREB are associated in SW480 cells with the endogenous 5' flanking region -219/+7 of FSCN1. Histone binding to the promoter region of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used as a positive control (data not shown). AhR and CREB were each reproducibly detected in association with the -219/+7 region of the endogenous FSCN1 promoter and were enriched relative to the negative control immunoprecipitations (Fig. 6C). To examine whether these associations were specific to fascin-positive carcinoma cells, the analysis was extended to SW1222 cells. In immunoprecipitates from chromatin extracts of SW1222 cells, no enrichment of AhR nor CREB in association with the -219/+7 region of the FSCN1 promoter was detectable relative to the negative control imunoprecipitation (Fig. 6D). To confirm the specificity of immunoprecipitation, the PCR products from the input samples of both SW480 and SW1222 cells were sequenced: both DNAs had exactly the same sequence that corresponded to the human genome reference sequence for FSCN1 as shown in Fig. 4A.
###end p 42
###begin p 43
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 619 626 619 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6E</xref>
###xml 879 886 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6E</xref>
To quantify the association of CREB and AhR with the -219/+7 region of the FSCN1 promoter in SW480 and SW1222 cells, quantitative real-time PCR (qRT-PCR) was carried out. DNA samples from chromatin immunoprecipitates from SW1222 and SW480 cells were analysed in comparison to the respective input DNA and DNA from negative control IgG immunoprecipitates, all in the same sets of reactions. For the reactions from SW480 cells, the CREB and AhR immunoprecipitations, and GAPDH used as a positive control, all resulted in significant enrichment of the -219/+7 promoter region relative to IgG control immunoprecipitations (Fig. 6E). For the reactions from SW1222 cells, only the GAPDH positive control was significantly enriched relative to negative control immunoprecipitations. A small enrichment for the AhR immunoprecipitations did not reach statistical significance (p = 0.38) (Fig. 6E).
###end p 43
###begin p 44
###xml 159 164 <span type="species:ncbi:9606">human</span>
These results demonstrate a correlation between the association of CREB and AhR with the -219/+7 region of the FSCN1 promoter and fascin protein expression in human colon carcinoma cells.
###end p 44
###begin title 45
###xml 63 71 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
Association of beta-catenin with the -219/+114 region of human fascin-1 is not specific to fascin-positive carcinoma cells
###end title 45
###begin p 46
###xml 106 114 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 133 136 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 138 141 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 198 204 195 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4</xref>
###xml 432 438 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN-1</italic>
###xml 654 661 645 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g007">Fig. 7A</xref>
###xml 785 792 776 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g007">Fig. 7B</xref>
###xml 899 904 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1249 1255 1234 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 1450 1461 1432 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g007">Fig. 7C, 7D</xref>
###xml 1625 1630 1604 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1090 1095 <span type="species:ncbi:9606">human</span>
###xml 1222 1227 <span type="species:ncbi:9606">human</span>
###xml 1229 1239 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1244 1247 <span type="species:ncbi:9615">dog</span>
###xml 1675 1680 <span type="species:ncbi:9606">human</span>
There are conflicting reports in the literature on the relevance of beta-catenin signaling for regulating fascin-1 promoter activity [3], [8]. In view that the candidate TCF binding motif (motif 9, Fig. 4) is highly conserved in mammals and that mutation of this site affected the transcriptional reporter activity of the -219/+114 region in SW480 cells, we examined the possible association of beta-catenin with this region of the FSCN-1 promoter and its specificity. By chromatin immunoprecipitation from SW480 extracts, the -219/+114 region was specifically enriched in beta-catenin immunoprecipitates compared to negative control immunoprecipitates (Fig. 7A). However, the identical result was obtained with chromatin immunoprecipitates prepared from fascin-negative SW1222 cells (Fig. 7B). Furthermore, beta-catenin was also found to be specifically associated with the -219/+114 region of the FSCN1 promoter in fascin-negative Namalwa B lymphocyte cells (data not shown). Thus, the association of beta-catenin with the -219/+114 region was not found to be specific to fascin-positive human carcinoma cells. From the bioinformatic analyses, we had identified a second candidate TCF binding motif that is conserved in human, chimpanzee and dog (Fig. 1, position indicated by asterisk). However, by chromatin immunoprecipitation, no specific association of beta-catenin with this region of the genome was detected in either SW480 or SW1222 cells (Fig. 7C, 7D) relative to the negative control immunoprecipitations. Collectively, these data do not support the hypothesis that beta-catenin has a specific role in regulating FSCN1 transcriptional activity in fascin-positive human carcinoma cells.
###end p 46
###begin title 47
###xml 46 51 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 101 106 <span type="species:ncbi:9606">human</span>
Analysis of beta-catenin association with the FSCN1 promoter region in fascin-positive and -negative human colon carcinoma cells.
###end title 47
###begin p 48
###xml 342 347 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
A, B, analysis of beta-catenin binding to the -219/+114 region of the FSCN1 promoter by chromatin immunoprecipitation from SW480 cells [A] and SW1222 cells [B]. Immunoprecipitation with RNA polymerase II antibody was used as a positive control and is shown in each set. C, D, analysis of beta-catenin binding to the -2384/-1412 region of the FSCN1 promoter by chromatin immunoprecipitation from SW480 cells [C] and SW1222 cells [D]. No specific association was detected.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 604 612 604 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 833 841 833 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1166 1171 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 588 593 <span type="species:ncbi:9606">human</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 1200 1205 <span type="species:ncbi:9606">human</span>
Because fascin up-regulation correlates with poor prognosis and metastatic progression in multiple human carcinomas, fascin is emerging as an attractive potential therapeutic target. We combined bioinformatic and experimental approaches to identify motifs within the FSCN1 promoter that are of functional relevance to the pathological expression of fascin in human carcinomas. By comparing the fascin-1 promoter region from six mammalian species, we obtained resolution for identification of candidate regulatory motifs in the human fascin-1 promoter. Similarly, distinctions between the human and mouse fascin-1 promoters that have been obscure from analysis of either species could be clarified. The central novel findings of our study are: a), the identification of two separate regions within the 5' flanking region of mammalian fascin-1 genes in which specific, highly conserved sequence motifs are concentrated; b), the identification of a combined action of the well-conserved CREB- and AhR-binding motifs in positive transcriptional regulation of FSCN1, and c), the identification that AhR and CREB transcription factors are specifically associated with the FSCN1 promoter in fascin-positive human colon carcinoma cells.
###end p 50
###begin p 51
###xml 709 717 709 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 870 878 870 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 211 216 <span type="species:ncbi:9606">human</span>
The availability of multiple sequenced mammalian genomes has greatly increased possibilities for making broadly based, and therefore more accurate, identification of evolutionarily conserved features within the human genome. This is particularly important for analyses of candidate transcription factor binding sites, for which the core motifs are under 10 nucleotides long, and which tend to be over-predicted by motif identification algorithms. With the benefit of genomic sequences from six mammals for multiple sequence alignment and motif analysis, we definitively identified two separate major regions of very high sequence conservation situated within 2 kb upstream of the translational start codon of fascin-1. Both regions contain multiple conserved motifs located in a conserved order, suggestive of important functional roles in transcriptional regulation of fascin-1.
###end p 51
###begin p 52
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 782 785 782 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Jawhari1">[4]</xref>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g006">Fig. 6A</xref>
###xml 914 922 914 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1264 1268 1264 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-GalYam1">[38]</xref>
###xml 252 257 <span type="species:ncbi:9606">human</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
Indeed, through analysis of the activity of a set of promoter reporter constructs we have demonstrated a central importance of the FSCN1 promoter region -219/+114, (that contains conserved region A), in providing positive transcriptional regulation in human carcinoma cells. We identified a commonality of regulatory mechanisms between fascin-positive breast and colon carcinoma cells and human fibroblasts that are constitutively fascin-positive. This implies that fascin up-regulation in carcinomas is likely to be mediated by aberrations in normal regulatory mechanism(s), rather than activation of a novel mechanism. We note that the basal low level of promoter reporter activity in SW1222 and T47D cells is in contrast to the complete absence of fascin protein in these cells ([4] and Fig. 6A of this study). We considered that DNA methylation might contribute to transcriptional repression of the endogenous fascin-1 gene in these cells. However, no increase in fascin protein was detected in SW1222 cells treated with the DNA methylation inhibitor 5-azacytidine for up to 72 h (unpublished observation). Other epigenetic mechanisms that would also be deficient in the plasmid context include other histone modifications or effects of chromatin conformation [38].
###end p 52
###begin p 53
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Bros1">[26]</xref>
###xml 399 404 399 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Bros1">[26]</xref>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Geyeregger1">[39]</xref>
###xml 134 139 <span type="species:ncbi:9606">human</span>
These results can be contrasted with a previous study of the activity of transcriptional regulatory elements in the FSCN1 promoter in human dendritic and monocyte cells. In this study, FSCN1 promoter reporter activity also correlated with the natural level of fascin protein in the cells; however, distinct transcriptional regulatory mechanisms were identified in the different cell types [26]. The FSCN1 promoter region -1600/-210 was found to contain positive regulatory activity in mature dendritic cells, whereas in monocytes or neuronal cells this region included repressor activity [26]. The identification of repressor activity within the region distal to -210 is comparable with our study. No transcriptional repressor proteins have yet been identified for the FSCN1 promoter, although it is of interest that activation of liver X receptor in lipopolysaccaride-matured dendritic cells reduces fascin protein levels [39]. However, a general conclusion emerging from the study with dendritic cells and our study is that, in all the cell types examined in both studies, the region -219/+114 has major transcriptional activity.
###end p 53
###begin p 54
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Bros1">[26]</xref>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 911 916 911 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1452 1456 1452 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ross1">[22]</xref>
###xml 1508 1516 1508 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 1646 1651 1646 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1676 1680 1676 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Megiorni1">[27]</xref>
###xml 958 963 <span type="species:ncbi:9606">human</span>
###xml 1080 1085 <span type="species:ncbi:9606">human</span>
The presence of candidate CREB- and AhR-binding motifs in proximity to the FSCN1 transcriptional start site has been noted [26], but the roles of these motifs or the relevant DNA-binding transcription factors in promoter activity were not investigated previously. Through unbiased methodologies for analysis of sequence conservation within the -219/+114 FSCN1 promoter region, combined with experimental analysis of the effects of point mutations on promoter reporter activity, we establish for the first time that the CREB- and AhR-binding motifs each contribute substantially to transcriptional activity of the FSCN1 promoter. The combined mutation of both motifs inhibited promoter reporter activity most strongly. We substantiated the concept of a direct functional role for the CREB and AhR transcription factors by the following novel findings: 1) both proteins are physically associated with the -219/+7 FSCN1 promoter region in fascin-positive SW480 human colon carcinoma cells; 2), as confirmed by qRT-PCR, these associations are not detectable in fascin-negative SW1222 human colon carcinoma cells. It should be noted that the chromatin immunoprecipitation method does not identify the precise transcription factor binding site on the DNA; additional approaches such as EMSA or use of promoter decoys will be required to confirm this point. CREB binds as a dimer to DNA and then recruits either CBP or p300 as a co-activator of transcription [22]. CBP has been demonstrated to impact the levels of fascin-1 transcript and protein in differentiating NT2 neuronal cells and is thus a plausible candidate for a co-activator of CREB on the FSCN1 promoter in SW480 cells [27].
###end p 54
###begin p 55
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ghosh1">[40]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Adams2">[32]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Zhang1">[41]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Ionov1">[42]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Hashimoto5">[14]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Puppa1">[17]</xref>
###xml 1009 1014 1009 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1321 1325 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Barouki1">[43]</xref>
###xml 1415 1419 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Schlezinger1">[44]</xref>
###xml 1544 1548 1544 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Yang1">[45]</xref>
###xml 1759 1764 1759 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
Increased expression of CREB is correlated with high grade prostate carcinomas [40], however, there are limited data on the relationship between CREB expression and the progression and/or metastasis of colon carcinomas. Mechanisms of CREB activation are complex and involve cAMP-activated phosphorylation of CREB plus additional processes to generate signaling specificity [32], [41]. Thus, we consider it unlikely that there is a simple relationship between levels of CREB, pCREB, and tumour status. Interestingly, both CBP and p300 are frequently mutated in colon cancer cell lines with microsatellite instability [42]. Microsatellite instability is most frequent in tumours of the proximal colon, which are the tumours that most frequently over-express fascin [14], [17]. We hypothesise that up-regulation of fascin transcription in colon carcinomas might take place in conjunction with altered regulation of the CREB complex. Further complexity is indicated by our finding that AhR binding to the -219/+7 FSCN1 promoter region also regulates promoter activity. AhR is best known for its roles in pathways of metabolism of environmental chemicals, such as dioxin, to toxic or carcinogenic intermediates. Roles of AhR in the regulation of cell proliferation, apoptosis, and cell adhesion and migration are now emerging [43]. These activities have been proposed to contribute to the progression of mammary tumours [44]. Ligand-independent AhR up-regulation has been documented in tumours and linked with promotion of cell proliferation (e.g., [45]). Similar to CREB, AhR functions in the context of transcriptional coactivators or corepressors: it will be of future interest to identify the upstream signaling mechanisms by which CREB and AhR binding to the FSCN1 promoter are activated in carcinoma cells.
###end p 55
###begin p 56
###xml 70 75 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 213 221 210 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 231 234 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 236 239 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 397 401 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Polakis1">[28]</xref>
###xml 500 508 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 529 532 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Grothey1">[3]</xref>
###xml 534 537 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Vignjevic1">[8]</xref>
###xml 751 757 742 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g001">Fig. 1</xref>
###xml 770 777 761 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g004">Fig. 4A</xref>
###xml 872 877 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1210 1213 1195 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not</italic>
###xml 1703 1708 1679 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 1960 1964 1933 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Li1">[46]</xref>
###xml 2074 2079 2044 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
###xml 1385 1390 <span type="species:ncbi:9606">human</span>
###xml 1392 1402 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1407 1410 <span type="species:ncbi:9615">dog</span>
###xml 1618 1623 <span type="species:ncbi:9606">human</span>
We also analysed the possible link between beta-catenin signaling and FSCN1 promoter activity. This pathway has been proposed for a number of years but, to date, has only been analysed with reference to the mouse fascin-1 promoter [3], [8]. Under conditions of active beta-catenin signaling, beta-catenin associates with DNA through its interaction with LEF1/TCF DNA binding transcription factors [28]. Although multiple candidate TCF binding sites can be identified in the individual mouse or human fascin-1 promoter sequences ([3], [8]; our observations), phylogenomic analysis of conserved motifs demonstrates that, in fact, only one TCF site is conserved between primates and mice. This site is located at the proposed transcriptional start site (Fig. 1, motif 9 in Fig. 4A). Experimentally, we found that an inactivating point mutation of this site altered -219/+114 FSCN1 promoter reporter activity in SW480 cells but did not affect promoter activity in COS-7 cells. Furthermore, chromatin immunoprecipitation for beta-catenin carried out in both fascin-positive and negative- human colon carcinoma cells demonstrated that an association of beta-catenin with the endogenous -219/+114 promoter region did not correlate with fascin protein levels. The specificity of this result was confirmed by examination of a more distal region containing a TCF binding motif conserved between human, chimpanzee and dog, for which no specific association of beta-catenin was detected in either cell type. Overall, these data do not support the hypothesis that beta-catenin signaling specifically regulates fascin expression in human carcinoma cells. The role of beta-catenin in constitutive association with the FSCN1 promoter is unclear at this time. However, beta-catenin has been demonstrated to participate in transcription factor complexes that include additional components, such as CBP/p300, that exhibit both transcriptional repressor and activation properties [46]: we speculate that such an alternative complex may represent the context of beta-catenin associated with the FSCN1 promoter.
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 487 492 <span type="species:ncbi:9606">human</span>
We have identified that the conserved CREB and AhR binding motifs within the promoter region of the fascin-1 gene are major and specific determinants of transcriptional activity, and that the association of these transcription factors with the corresponding FSCN1 promoter region is specifically elevated in fascin-positive human colon carcinoma cells. These novel findings will guide further analysis of the environmental cues that activate aberrant expression of fascin in early stage human carcinomas.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin title 60
Cell lines and other materials
###end title 60
###begin p 61
###xml 325 326 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 475 476 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 141 145 <span type="species:ncbi:9913">calf</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:10090">Mouse</span>
###xml 435 441 <span type="species:ncbi:9986">rabbit</span>
###xml 510 516 <span type="species:ncbi:9986">Rabbit</span>
###xml 597 603 <span type="species:ncbi:9986">Rabbit</span>
###xml 647 652 <span type="species:ncbi:10090">Mouse</span>
###xml 711 716 <span type="species:ncbi:10090">Mouse</span>
###xml 770 775 <span type="species:ncbi:10090">Mouse</span>
###xml 865 871 <span type="species:ncbi:9986">rabbit</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
SW480 and SW1222 human colon adenocarcinoma cells, human dermal fibroblasts (HDF) and COS-7 cells were cultured in DMEM containing 10% fetal calf serum (FCS). MDA-MB-231 and T47D human breast carcinoma cells were cultured in DMEM containing 5% FCS. All cells were maintained at 37degreesC in a humidified, temperature- and CO2-controlled incubator. Mouse monoclonal antibody to cAMP response element-binding protein (CREB) (86B10) and rabbit monoclonal to phosphoCREB-S133-PO4 (87G3) were from Cell Signaling. Rabbit polyclonal IgG to CREB used for chromatin immunoprecipitation was from Upstate. Rabbit polyclonal IgG to AhR was from Santa Cruz. Mouse monoclonal antibody to beta-actin (AC-15) was from Sigma. Mouse monoclonal antibody to fascin (55k-2) was from Dako. Mouse monoclonal antibody to beta-catenin (clone 14) was from BD Transduction Labs. Non-immune rabbit or mouse IgG was from Sigma.
###end p 61
###begin title 62
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ascin-1</italic>
Bioinformatic analyses of the 5' flanking regions of mammalian fascin-1 genes
###end title 62
###begin p 63
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fascin-1</italic>
###xml 188 200 188 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Lander1">[47]</xref>
###xml 232 247 232 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Chimpanzee1">[48]</xref>
###xml 277 291 277 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Rhesus1">[49]</xref>
###xml 321 343 321 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis lupus familiaris</italic>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-LindbladToh1">[50]</xref>
###xml 373 385 373 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Mouse1">[51]</xref>
###xml 432 449 432 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Gibbs1">[52]</xref>
###xml 188 200 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 232 247 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 277 291 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 321 343 <span type="species:ncbi:9615">Canis lupus familiaris</span>
###xml 373 385 <span type="species:ncbi:10090">Mus musculus</span>
###xml 432 449 <span type="species:ncbi:10116">Rattus norvegicus</span>
Nucleotide sequences for 5.5 kb of DNA 5' to the ATG codon of fascin-1 genes from six mammalian species were obtained from the Entrez Genomes division of NCBI (). The sequences were from: Homo sapiens[47], Build 36.2, chromosome 7; Pan troglodytes[48] Build 2.1, chromosome 7; Macaca mulatta[49] Build 1.1, chromosome 3; Canis lupus familiaris[50] Build 2.1, chromosome 6; Mus musculus[51] Build 37.1, chromosome 5 (5 86.0 cM), and Rattus norvegicus[52] RGSC v3.4, chromosome 12.
###end p 63
###begin p 64
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Poirot1">[53]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Blanchette1">[29]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Kel1">[54]</xref>
###xml 797 801 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Knppel1">[55]</xref>
###xml 1029 1033 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Loots1">[56]</xref>
###xml 1187 1191 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Sosinsky1">[57]</xref>
###xml 1332 1336 1330 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Fang1">[58]</xref>
DNA sequence conservation between the species was examined by multiple sequence alignment of a 2 kb region 5' to the ATG codon, using TCOFFEE Regular [53] at EMBnet (). The sequences were also analysed by the algorithm FootPrinter 3.0 () that identifies short highly conserved regions, according to parsimony criteria in combination with the use of established phylogenetic relationships [29]. The motif size was set to 10 and a maximum parsimony score of 2 was used. Candidate transcription factor binding sites were identified in each sequence using Match 1.0 Public () with the algorithm set to mimimise false negatives [54]. Match 1.0 uses a library of mononucleotide position specific weight matrices from TRANSFAC(R) 6.0 to predict candidate binding sites for specific transcription factors [55]. Pairwise analyses were also made through rVISTA 2.0 () in which pairwise sequence alignment is combined with analysis against the TRANSFAC library of matrices to identify conserved candidate transcription factor binding sites [56]. Because of the natural variety of TCF-binding nucleotide sequences, candidate TCF binding sites were also identified with the algorithm Target Explorer [57] () using a customised position specific weight matrix based on a library of motifs, compiled from a previous analysis of TCF binding motifs [58] in combination with additional TCF motifs from the literature, with the minimum threshold set to 4. All results from the motif identification programmes were also examined against the TCOFFEE and FootPrinter sequence alignments.
###end p 64
###begin title 65
Construction of promoter reporter plasmids
###end title 65
###begin p 66
###xml 103 111 103 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s002">Table S1</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSNC1</italic>
###xml 626 631 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 665 686 665 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s002">supplementary Table 1</xref>
###xml 1278 1284 1278 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005130-g002">Fig. 2</xref>
###xml 1413 1434 1413 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s002">supplementary Table 1</xref>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 1214 1217 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Firefly luciferase cDNA, the gift of Donna Driscoll, CCF, was amplified by PCR with primers 294F/295R (Table S1). The PCR product was subcloned into pcDNA3.1/V5-His TOPO mammalian expression plasmid by the TOPO cloning method according to manufacturer's procedures (Invitrogen). This plasmid was designated pcDNA3.1Luc. The BAC clone CTB-161C1 (GenBank AC006483), that contains 196416 bp of DNA from human chromosome 7 including the region of FSNC1 in pBeloBAC11, was from Invitrogen. BAC DNA was prepared with the QIAGEN Large DNA construct kit and used as a template for PCR to amplify portions of the 5' flanking region of FSCN1 using the primer pairs listed in supplementary Table 1. The entire 3.1 kb 5' flanking region was sub-cloned into pcDNA3.1Luc by a multi-step cloning procedure. First, the region -2952/-946 was amplified with PCR primers 352F/369R, digested with BamHI and KpnI and ligated into BamH1/KpnI digested pBS-SK. The region -1512/+114 was amplified with PCR primers 357F/353R, digested with XcmI and KpnI and ligated 3' to the -2952/-1512 region in pBS-SK digested with XcmI/KpnI. The 3.1 kb insert was digested from pBS-SK with BamHI and KpnI and subcloned into pcDNA3.1Luc from which the CMV promoter region had been removed by Bgl II/Kpn I digestion (Fig. 2; designated pcFSCN-2952/+114Luc). pcFSCN1-1582/+114Luc and pcFSCN1-219/+114Luc were generated by PCR with the primers listed in supplementary Table 1, followed by HindIII/KpnI digestion of the PCR product and ligation into correspondingly digested pcFSCN-2952/+114Luc. For the internal promoter deletion (Delta-1582/-50), PCR was carried out with primers 529F/530R, the product digested with AatII, and ligated in AatII-digested pcFSCN-2952/+114Luc. pcFSCN1-50/+114Luc was prepared by AatII digestion of pcFSCN-2952/+114Luc and self-ligation. pcFSCN1-43/+114Luc was prepared by AatII digestion of pcFSCN-2952/+114Luc, blunting of ends with T4 DNA polymerase, and self-ligation. All sequences were checked by automated DNA sequencing, carried out by CCF Genomics core facility.
###end p 66
###begin title 67
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
Preparation of point mutations in the FSCN1 promoter
###end title 67
###begin p 68
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Yang2">[59]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Korinek1">[60]</xref>
###xml 923 944 923 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005130.s002">supplementary Table 1</xref>
Sites for point mutation in the FSCN1 0.21 kb promoter region were selected based on the bioinformatic analyses of candidate transcription factor binding site core motifs and their conservation in six mammalian species. The mutations were designed based on known inactivating mutations of the motifs. All the designed mutant nucleotide sequences were re-analysed in Match 1.0 Public to check for loss of the specific transcription factor binding site and that no new binding sites were generated. The CREB binding site point mutant was based on previous inactivating mutations [59]. The TCF binding site point mutant was designed from the FOPFLASH plasmid sequence [60]. All mutations were prepared by PCR-based mutagenesis of the 0.21 kb promoter region in pcDNA3.1Luc plasmid, using the QuickChange II XL Site-directed mutagenesis kit (Stratagene) according to manufacturer's procedures and oligonucleotide primers as in supplementary Table 1. Sequences were confirmed by automated DNA sequencing of the entire 0.21 kb promoter region.
###end p 68
###begin title 69
Dual luciferase promoter reporter assay
###end title 69
###begin p 70
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;14</sup>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSCN1</italic>
###xml 397 404 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 834 841 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1063 1070 1055 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1468 1469 1460 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1146 1149 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1256 1259 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
1x105 cells were plated per 14 mm well in 24-well plates for 24 hrs before transfection, with the exception of COS-7 cells that were plated for 6 hrs. All cells were transiently co-transfected with 5.5x10-14 moles of each FSCN1 promoter-luciferase reporter construct and 0.034 microg of pRL-TK plasmid (Promega) using PolyFect (QIAGEN) according to the manufacturer's instructions. pRL-TK encodes Renilla (sea-pansy) luciferase and provided an internal control for transfection efficiencies. Appropriate amounts of pBlueScript plasmid were included in the co-transfection to maintain the total mass of DNA in each transfection at 0.34 microg. After 24 h, cell lysates were prepared and transcriptional activities measured using the Dual-luciferase reporter assay system according to manufacturer's instructions (Promega). Firefly and Renilla luciferase activities were measured in a MLX luminometer (DYNEX Technologies, Chantilly, VA). Relative firefly luciferase activity was calculated by dividing the absolute activity of firefly luciferase by the activity of Renilla luciferase. Within each cell line, the normalised reporter activity of the CMV promoter was set as 1, and the activities of the FSCN1 reporter constructs expressed as a fraction of the CMV activity. At least three independent experiments were carried out for all cells and constructs, with duplicate or triplicate samples in each experiment. Data were analysed statistically by unpaired Student's t-test.
###end p 70
###begin title 71
Chromatin Immunoprecipitation
###end title 71
###begin p 72
The protocol for chromatin immunoprecipitation was based on the EZ-ChIP kit (Upstate) and manufacturer's procedures, with optimisation for the cell lines and antibodies tested. Briefly, SW480 or SW1222 cells were seeded in 10 cm dishes for 48 hours and protein-DNA complexes were cross-linked with 1% formaldehyde for 10 min. Cross-linking was quenched by addition of 125 mM glycine. Cells were washed with phosphate-buffered saline, harvested, resuspended in 1% SDS, 10 mM EDTA, 50 mM Tris.HCl, pH 8.1, lysis buffer containing protease inhibitors, and sonicated on ice by 6 pulses of 10 seconds duration each at the 30% amplitude setting of a BRANSON Digital sonifier (BRANSON, Danbury, CT). Soluble chromatin was collected by centrifugation and an aliquot taken to represent the input fraction. The remaining supernatant was incubated with 60 microl of protein G-Sepharose (50% v/v slurry) under rotation for 1 h at 4degreesC for pre-clearing. The supernatant was transferred to a new microcentrifuge tube, 4 microg of each antibody added with mixing for 5 h at 4degreesC, of for the beta-catenin antibody 2 microg was used and the sample mixed overnight at 4degreesC. Protein G-Sepharose (40 microl of 50% v/v slurry) was then added for 1 h with mixing at 4degreesC. Bead pellets were washed for 5 min in 1 ml of low salt wash buffer, twice in high salt wash buffer, once in lithium chloride wash buffer, and twice in TE. Protein-DNA complexes were eluted in 200 microl of elution buffer and the cross-links reversed by overnight incubation at 65degreesC. DNA was purified using QIAamp DNA mini kit (QIAGEN) and eluted in 75 microl of 10 mM Tris.Cl, 0.5 mM EDTA, pH 9.0. 4 microl aliquots were used as templates for PCR amplification with primers 601F/603R (for CREB and AhR), or 353F/354R or 383F/384R (for beta-catenin) and 449F/450R (for GAPDH). Reactions were carried out with annealing at 58degreesC and Hercules DNA polymerase (Stratagene) for 29 cycles. Reaction products were analysed on 1.5% agarose gels or by quantitative real-time PCR. Amplified DNAs were identified as the correct genomic regions by DNA sequencing.
###end p 72
###begin title 73
Quantitative real-time PCR
###end title 73
###begin p 74
###xml 541 542 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 700 701 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 740 741 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sup>
###xml 880 881 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Reactions were performed on input DNA samples and DNA from chromatin immunoprecipitations prepared from SW1222 and SW480 cells using the Express SYBR GreenER qPCR SuperMix Universal (Invitrogen) and were run on an Prism 7000 instrument (Applied Biosystems) using 25 microl reaction volumes. Cycling conditions were 50degreesC for 2 mins, 95degreesC for 2 mins, followed by 40 cycles of 95degreesC for 15 sec and 60degreesC for 1 min. The relative proportion of immunoprecipitated promoter fragments was determined from the threshold cycle (CT) for each PCR reaction after normalization relative to input DNA. Fold enrichment in the test immunoprecipitations was calculated as two to the power [mean CT value for that sample minus the mean CT value from the IgG control immunoprecipitation] and were analysed statistically against the IgG control immunoprecipitation by two-tailed t test.
###end p 74
###begin title 75
Gel electrophoresis and immunoblotting
###end title 75
###begin p 76
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005130-Anilkumar1">[61]</xref>
###xml 413 419 <span type="species:ncbi:9913">bovine</span>
###xml 531 537 <span type="species:ncbi:9913">bovine</span>
Whole cell lysates were prepared in SDS-PAGE sample buffer buffer (2% SDS, 10% glycerol, 50 mM Tris-HCl, pH 6.8). All samples were electrophoresed on 10% polyacrylamide gels under reducing conditions and transferred to polyvinylidene difluoride membranes (Millipore) using a semidry transfer blot system. Blocking and washing with Tris-buffered saline containing 1% Tween 20 (TBS-T), 2% skim milk powder and 0.5% bovine serum albumin (Sigma) was used for all antibodies except the pS133CREB antibody, for which TBS-T containing 5% bovine serum albumin was used. After incubation for 1 h with primary antibodies, or over-night with the phospho-specific antibodies, blots were developed with alkaline phosphatase-conjugated secondary antibodies and enhanced chemiluminescence (ECL) as described [61]. Quantitative analysis was performed using NIH Image J version 1.38.
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin p 78
###xml 382 387 <span type="species:ncbi:9606">human</span>
TCOFFEE multiple sequence alignment of the 5' flanking region of the fascin-1 gene from six mammalian species. 2 kb of sequence was extracted from each of the indicated genomes. Black shading indicates identical nucleotides, grey shading indicates conservation in less than 50% of the sequences. Sequences are numbered with reference to the transcriptional start site as +1; in the human sequence the ATG codon is at +122.
###end p 78
###begin p 79
(0.27 MB RTF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
List of oligonucleotides used for PCR-based sub-cloning, mutagenesis, or chromatin immunoprecipitation analysis.
###end p 81
###begin p 82
(0.02 MB RTF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
We thank Graham Casey for discussion, Gary Wildey for advice on luciferase reporter assays, Unni Chandrasekharan for advice on qRT-PCR, and CCF Genomics core for DNA sequencing.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
The actin cytoskeleton in normal and pathological cell motility.
###end article-title 86
###begin article-title 87
###xml 55 60 <span type="species:ncbi:9606">human</span>
Expression of the cytoskeleton linker protein ezrin in human cancers.
###end article-title 87
###begin article-title 88
###xml 96 101 <span type="species:ncbi:9606">human</span>
C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
###end article-title 88
###begin article-title 89
Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.
###end article-title 89
###begin article-title 90
###xml 52 57 <span type="species:ncbi:9606">human</span>
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
###end article-title 90
###begin article-title 91
Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells.
###end article-title 91
###begin article-title 92
Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis.
###end article-title 92
###begin article-title 93
###xml 92 97 <span type="species:ncbi:9606">human</span>
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
###end article-title 93
###begin article-title 94
Roles of fascin in cell adhesion and motility.
###end article-title 94
###begin article-title 95
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
###end article-title 95
###begin article-title 96
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer.
###end article-title 96
###begin article-title 97
###xml 49 54 <span type="species:ncbi:9606">human</span>
The prognostic relevance of fascin expression in human gastric carcinoma.
###end article-title 97
###begin article-title 98
###xml 19 24 <span type="species:ncbi:9606">human</span>
Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?
###end article-title 98
###begin article-title 99
Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
###end article-title 99
###begin article-title 100
The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course.
###end article-title 100
###begin article-title 101
Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
###end article-title 101
###begin article-title 102
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma.
###end article-title 102
###begin article-title 103
Genes that mediate breast cancer metastasis to lung.
###end article-title 103
###begin article-title 104
Fascins, a family of actin bundling proteins.
###end article-title 104
###begin article-title 105
###xml 12 17 <span type="species:ncbi:9606">human</span>
Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein.
###end article-title 105
###begin article-title 106
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis.
###end article-title 106
###begin article-title 107
The actin-bundling protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells.
###end article-title 107
###begin article-title 108
Fascin is involved in the antigen presentation activity of mature dendritic cells.
###end article-title 108
###begin article-title 109
###xml 60 65 <span type="species:ncbi:9606">human</span>
Expression of the actin-bundling protein fascin in cultured human dendritic cells correlates with dendritic morphology and cell differentiation.
###end article-title 109
###begin article-title 110
Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.
###end article-title 110
###begin article-title 111
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human fascin gene promoter is highly active in mature dendritic cells due to a stage-specific enhancer.
###end article-title 111
###begin article-title 112
Minor expression of fascin-1 gene (FSCN1) in NTera2 cells depleted of CREB-binding protein.
###end article-title 112
###begin article-title 113
The many ways of Wnt in cancer.
###end article-title 113
###begin article-title 114
FootPrinter: A program designed for phylogenetic footprinting.
###end article-title 114
###begin article-title 115
###xml 34 39 <span type="species:ncbi:9606">human</span>
Steroid receptor analyses of nine human breast cancer cell lines.
###end article-title 115
###begin article-title 116
Relevance of breast cancer cell lines as models for breast tumours: an update.
###end article-title 116
###begin article-title 117
A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1.
###end article-title 117
###begin article-title 118
Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.
###end article-title 118
###begin article-title 119
Role of the Per/Arnt/Sim Domains in Ligand-dependent Transformation of the Aryl Hydrocarbon Receptor.
###end article-title 119
###begin article-title 120
Transcriptional regulation by the phosphorylation-dependent factor CREB.
###end article-title 120
###begin article-title 121
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
pCREB is Involved in neural induction of mouse embryonic stem cells by RA.
###end article-title 121
###begin article-title 122
Hypoxia-induced endothelial NO synthase gene transcriptional activation is mediated through the tax-responsive element in endothelial cells.
###end article-title 122
###begin article-title 123
Cancer epigenetics: modifications, screening, and therapy.
###end article-title 123
###begin article-title 124
Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin.
###end article-title 124
###begin article-title 125
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
###end article-title 125
###begin article-title 126
###xml 120 125 <span type="species:ncbi:9606">human</span>
Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.
###end article-title 126
###begin article-title 127
A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability.
###end article-title 127
###begin article-title 128
The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein.
###end article-title 128
###begin article-title 129
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.
###end article-title 129
###begin article-title 130
###xml 78 83 <span type="species:ncbi:9606">human</span>
The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells.
###end article-title 130
###begin article-title 131
CBP/p300 are bimodal regulators of Wnt signaling.
###end article-title 131
###begin article-title 132
###xml 14 19 <span type="species:ncbi:9606">Human</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome.
###end article-title 132
###begin article-title 133
###xml 24 34 <span type="species:ncbi:9598">chimpanzee</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Initial sequence of the chimpanzee genome and comparison with the human genome.
###end article-title 133
###begin article-title 134
###xml 46 60 <span type="species:ncbi:9544">rhesus macaque</span>
Evolutionary and biomedical insights from the rhesus macaque genome.
###end article-title 134
###begin article-title 135
###xml 78 81 <span type="species:ncbi:9615">dog</span>
Genome sequence, comparative analysis and haplotype structure of the domestic dog.
###end article-title 135
###begin article-title 136
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Initial sequencing and comparative analysis of the mouse genome.
###end article-title 136
###begin article-title 137
###xml 29 39 <span type="species:ncbi:10116">Norway rat</span>
Genome sequence of the Brown Norway rat yields insights into mammalian evolution.
###end article-title 137
###begin article-title 138
Tcoffee@igs: A web server for computing, evaluating and combining multiple sequence alignments.
###end article-title 138
###begin article-title 139
MATCHtrade mark: a tool for searching transcription factor binding sites in DNA sequences.
###end article-title 139
###begin article-title 140
TRANSFAC(R) retrieval program: a network model database of eukaryotic transcription regulating sequences and proteins.
###end article-title 140
###begin article-title 141
rVista 2.0: evolutionary analysis of transcription factor binding sites.
###end article-title 141
###begin article-title 142
Target Explorer: an automated tool for the identification of new target genes for a specified set of transcription factors.
###end article-title 142
###begin article-title 143
###xml 91 101 <span type="species:ncbi:7227">Drosophila</span>
C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila.
###end article-title 143
###begin article-title 144
Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells.
###end article-title 144
###begin article-title 145
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
###end article-title 145
###begin article-title 146
Interaction of fascin and protein kinase Calpha: a novel intersection in cell adhesion and motility.
###end article-title 146
###begin p 147
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 147
###begin p 148
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by Association for International Cancer Research grant 04-033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 148

